Torno Capital, LLC Eye Point Pharmaceuticals, Inc. Transaction History
Torno Capital, LLC
- $387 Billion
- Q1 2025
A detailed history of Torno Capital, LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Torno Capital, LLC holds 3,000 shares of EYPT stock, worth $29,580. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,000Holding current value
$29,580% of portfolio
0.0%Shares
0 transactions
Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
---|
Others Institutions Holding EYPT
# of Institutions
164Shares Held
71.6MCall Options Held
232KPut Options Held
207K-
Cormorant Asset Management, LP Boston, MA8.33MShares$82.1 Million4.79% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$67.1 Million1.61% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.2MShares$61.1 Million0.07% of portfolio
-
Franklin Resources Inc San Mateo, CA4.15MShares$40.9 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.09MShares$40.3 Million0.05% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $336M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...